CoChat
Cited by 192

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Anxiolytic Effects of Repeated Cannabidiol Treatment in Teenagers With Social Anxiety Disorders

Open access
Masataka, Nobuo · 2019 · Frontiers in Psychology

Abstract

Accumulated evidence indicates that cannabidiol (CBD), a nonpsychotomimetic and nonaddictive main component of the Cannabis sativa plant, reverses anxiety-like behaviour. The purpose of the present study was to assess the efficacy of CBD treatment for Japanese late teenagers with social anxiety disorder (SAD). Thirty-seven 18 - 19 years old Japanese teenagers with SAD and avoidant personality disorder receive, in a double-blind study, cannabis oil (n = 17) containing 300 mg CBD or placebo (n = 20) daily during 4 weeks. SAD symptoms were measured at the beginning and end of the treatment period using the Fear of Negative Evaluation Questionnaire and the Liebowitz Social Anxiety Scale. CBD significantly decrease anxiety measured by both scales. The results indicate that CBD could be a useful option to treat social anxiety.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fpsyg.2019.02466

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 14

  1. 2000, Diagnostic and statistical manual of mental disorders. 4th Edn, 1
  2. Blessing, 2015, Cannabidiol as a potential treatment for anxiety disorders, Neurotherapeutics, 12, 825, 10.1007/s13311-015-0387-1 · DOI · Paper page
  3. De Gregorio, 2019, Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain, Pain, 160, 136, 10.1097/j.pain.0000000000001386 · DOI · Paper page
  4. Di Nardo, 1994, Anxiety disorders interview schedule for DSM-IV (ADIS-IV), 1
  5. First, 1997, User’s guide for the structured clinical interview for DSM-IV Axis II personality disorders (SCD-II), 1
  6. Masataka, 2003, The onset of language, 1, 10.1017/CBO9780511489754 · DOI
  7. McGuire, 2018, Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized control trial, Am. J. Psychiatry, 175, 225, 10.1176/appi.ajp.2017.17030325 · DOI · Paper page
  8. Nordahl, 2016, Paraxetine, cognitive therapy or their combination in the treatment of social anxiety disorder with and without avoidant personality disorder: a randomized clinical trial, Psychother. Psychosom., 85, 346, 10.1159/000447013 · DOI
  9. Ogino, 2004, Managing categorization and social withdrawal in Japan: rehabilitation process in a private support group for hikikomorians, Int. J. Soc. Psychiatry, 13, 120, 10.1111/j.1475-6781.2004.00057.x · DOI
  10. Parker, 2006, Delta-9-tetrahydrocannabinol and cannabidiol, but not ondansetron, interfere with conditioned retching reactions elicited by a lithium-paired context in Suncus murinus: an animal model of anticipatory nausea and vomiting, Physiol. Behav., 87, 66, 10.1016/j.physbeh.2005.08.045 · DOI
  11. Ryan, 2012, Treating adolescents with social anxiety disorders in schools, Child Adolesc. Psychiatr. Clin. N. Am., 21, 1050118, 10.1016/j.chc.2011.08.011 · DOI
  12. Saito, 2007, Why hikikomori is cured?, 1
  13. Scuderi, 2009, Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders, Psychother. Res., 23, 597, 10.1002/ptr.2625 · DOI · Paper page
  14. Teo, 2010, A new form of social withdrawal in Japan: a review of Hikikomori, Int. J. Soc. Psychiatry, 56, 175, 10.1177/0020764008100629 · DOI · Paper page

Cited by

See all 192

Metadata

Authors
Masataka, N.
Venue
Frontiers in Psychology
Published
2019-11-08
Volume
10
Pages
2466-2466
ISSN
1664-1078 (ISSN-L)
OpenAlex
W2981783294
Cited by
192
References
15
FWCI
11.75
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anxiolytic Effects of Repeated Cannabidiol Treatment in Teenagers With Social Anxiety Disorders. https://app.cochat.ai/papers/10.3389/fpsyg.2019.02466
The paper
Masataka, N. (2019). Anxiolytic Effects of Repeated Cannabidiol Treatment in Teenagers With Social Anxiety Disorders. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2019.02466

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.